$7.040
-0.527 (-7.49%)Zum Schluss
- High
- 7.240
- Open
- 6.840
- VWAP
- 6.86
- Vol
- 11.63M
- Mkt Cap
- 1.43M
- Low
- 6.290
- Amount
- 79.77M
- EV/EBITDA, TTM
- 0.00
180 Life Sciences Corp. is a biotechnology company, which focuses on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. Its programs include Anti-TNF (Clinical), Synthetic Cannabinoid Analogs (SCAs), and a7nAChR (Preclinical). The Company also operates a back-end technology platform to operate an online blockchain casino.
Bewertungskennzahlen
Event-Zeitleiste
News
4.509-02BenzingaEXCLUSIVE: Top 20 Most-Searched Stocks on Benzinga Pro for August – How Do Opendoor, Palantir, BitMine Immersion, and Apple Rank?
9.508-15BenzingaWhy KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
4.508-15BenzingaStock Market Today: S&P 500, Nasdaq 100 Futures Trade Mixed— UnitedHealth, 180 Life Sciences, Intel In Focus
7.008-15BenzingaApplied Materials Issues Weak Outlook, Joins Globant, Sandisk And Other Big Stocks Moving Lower In Friday's Pre-Market Session
2.008-15Benzinga180 Life Sciences Stock Slides After-Hours As Ethereum's Decline Triggers Massive Sell-Off
ATNF FAQ — answered by Alphio AI
180 Life Sciences Corp. is a biotechnology company, which focuses on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. Its programs include Anti-TNF (Clinical), Synthetic Cannabinoid Analogs (SCAs), and a7nAChR (Preclinical). The Company also operates a back-end technology platform to operate an online blockchain casino. It operates in the Technology sector (PHARMACEUTICAL PREPARATIONS industry).
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.